STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 75 filers reported holding STEMLINE THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $72,680,000 | -46.9% | 7,900 | -50.6% | 0.02% | -42.3% |
| Q1 2017 | $136,800,000 | -43.9% | 16,000 | -29.8% | 0.03% | -44.7% |
| Q4 2016 | $243,960,000 | -4.1% | 22,800 | -3.0% | 0.05% | +6.8% |
| Q3 2016 | $254,505,000 | +80.7% | 23,500 | +13.0% | 0.04% | +76.0% |
| Q2 2016 | $140,816,000 | – | 20,800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| QVT Financial LP | 220,000 | $9,965,000 | 0.68% |
| Healthcare Value Capital, LLC | 16,464 | $746,000 | 0.65% |
| EAM Investors, LLC | 69,151 | $3,132,000 | 0.62% |
| Baker Brothers Advisors | 800,400 | $36,255,000 | 0.52% |
| Spark Investment Management LLC | 38,300 | $1,733,000 | 0.40% |
| Perceptive Advisors | 180,416 | $8,172,000 | 0.34% |
| SIGMA CAPITAL MANAGEMENT LLC | 175,000 | $7,926,000 | 0.33% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 129,915 | $5,885,000 | 0.23% |
| Visium Asset Management, LP | 150,000 | $6,794,000 | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 19,732 | $894,000 | 0.14% |